G1 kinases and transforming growth factor-beta signaling are associated with a growth pattern switch in

H C Huang1, P A Preisig

  • 1Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas 75235-8856, USA.

Abstract

Insights

Diabetes causes kidney enlargement through initial cell proliferation (hyperplasia) followed by cell growth (hypertrophy). This switch involves cell cycle regulators and TGF-beta signaling pathways in diabetic nephropathy.

Area of Science:

  • Nephrology
  • Cell Biology
  • Endocrinology

Background:

  • Diabetes mellitus can lead to nephromegaly, characterized by proximal tubule cell hyperplasia and hypertrophy.
  • The precise timing and underlying mechanisms of these cellular growth patterns in diabetic nephropathy remain unclear.

Purpose of the Study:

  • To investigate the temporal sequence of hyperplastic and hypertrophic growth in diabetic nephropathy.
  • To elucidate the molecular mechanisms, including cell cycle regulation and growth factor signaling, that mediate these growth patterns.

Main Methods:

  • Isolated renal proximal tubules from streptozotocin-induced diabetic rats were analyzed.
  • Kidney-to-body weight ratio, cell proliferation markers (5-bromo-2-deoxyuridine incorporation), and cell size markers (protein:DNA ratio) were measured.
  • Activities of cyclin-dependent kinases (cdk4/cyclin D, cdk2/cyclin E), expression of TGF-beta receptors, and Smad protein signaling were assessed.

Main Results:

  • Diabetic rats exhibited increased kidney weight, with initial hyperplastic growth (day 2) followed by hypertrophic growth (day 10).
  • Cell cycle kinase activities shifted, with increased cyclin D and cyclin E during hyperplasia, and sustained cyclin D with inhibited cyclin E during hypertrophy.
  • Transforming growth factor-beta (TGF-beta) receptor expression and Smad signaling were altered, suggesting a role in mediating the switch between growth phases.

Conclusions:

  • Diabetic nephropathy involves a sequential hyperplastic to hypertrophic proximal tubule cell growth pattern.
  • Cell cycle-dependent mechanisms, regulated by G1 kinase activity, mediate the transition to hypertrophy.
  • Modulation of TGF-beta receptor expression and Smad signaling pathways likely plays a critical role in regulating this growth pattern switch.

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Small GTPases - Ras and Rho01:24

Small GTPases - Ras and Rho

Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity:
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...